(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 114.74%1.08M | 423.88%2.35M | -87.42%1.49M | -81.29%621K | -106.08%-83K | -86.42%502K | -87.01%448K | 10,754.13%11.83M | -5.66%3.32M | 160.79%1.37M |
Net income from continuing operations | 9.35%1.24M | 270.17%599K | -82.49%542K | -56.56%563K | 28.88%-803K | -50.33%1.13M | -154.49%-352K | 250.51%3.1M | -50.70%1.3M | -427.57%-1.13M |
Operating gains losses | 56.95%-378K | -141.90%-220K | 84.28%-424K | 73.90%-678K | -44.82%607K | 57.25%-878K | -38.52%525K | -264.59%-2.7M | -96.97%-2.6M | 382.05%1.1M |
Depreciation and amortization | 16.95%835K | 21.56%857K | 33.53%2.92M | 18.47%744K | 37.21%756K | 38.10%714K | 43.88%705K | 3.31%2.19M | -19.28%628K | 56.09%551K |
Asset impairment expenditure | ---- | ---- | 25.45%414K | -3.33%319K | --4K | ---- | ---- | --330K | --330K | ---- |
Unrealized gains and losses of investment securities | ---- | ---- | -55.73%931K | ---- | ---- | ---- | ---- | 397.16%2.1M | ---- | ---- |
Remuneration paid in stock | -23.13%648K | 24.78%423K | 12.10%2.27M | 13.30%460K | 12.77%627K | -2.20%843K | 69.50%339K | 37.78%2.02M | 420.51%406K | 100.72%556K |
Deferred tax | 180.71%774K | -485.71%-82K | -115.26%-525K | -140.56%-245K | 38.88%693K | -208.36%-959K | -100.96%-14K | 734.95%3.44M | -57.49%604K | 791.07%499K |
Other non cashItems | -40.70%51K | 363.64%51K | -59.80%123K | -68.25%87K | -654.55%-61K | 681.82%86K | 10.00%11K | 800.00%306K | 2,390.91%274K | --11K |
Change In working capital | -368.05%-2.48M | 193.86%719K | -556.03%-4.76M | -665.22%-1.56M | -758.56%-1.91M | -144.38%-529K | -279.21%-766K | 167.44%1.04M | 154.87%276K | 90.47%-222K |
-Change in receivables | 44.94%129K | 4,521.21%1.53M | -149.32%-3.47M | 19.06%-1.6M | -8,981.82%-2M | -95.02%89K | 102.79%33K | -233.05%-1.39M | -861.78%-1.97M | 97.53%-22K |
-Change in inventory | -32.00%-1.52M | 129.46%418K | -193.69%-2.93M | -121.36%-211K | 73.83%-151K | 34.21%-1.15M | -518.58%-1.42M | 72.76%-998K | 228.65%988K | 76.84%-577K |
-Change in prepaid assets | 33.26%-311K | -488.89%-106K | 75.11%-225K | 128.18%104K | 153.08%155K | -654.76%-466K | 94.50%-18K | -345.32%-904K | -103.87%-369K | -264.97%-292K |
-Change in payables and accrued expense | -177.76%-776K | -275.24%-1.12M | -56.95%1.87M | -91.17%144K | -86.85%88K | -6.73%998K | -34.23%638K | 240.85%4.34M | 767.02%1.63M | -23.37%669K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 114.74%1.08M | 423.88%2.35M | -87.42%1.49M | -81.29%621K | -106.08%-83K | -86.42%502K | -87.01%448K | 10,754.13%11.83M | -5.66%3.32M | 160.79%1.37M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 25.57%-1.3M | 77.75%-1.97M | 43.86%-13.53M | 57.07%-1.15M | 33.76%-1.8M | 29.22%-1.74M | 45.59%-8.84M | -651.51%-24.1M | -148.79%-2.67M | -130.42%-2.72M |
Net PPE purchase and sale | 40.14%-880K | 75.33%-851K | 5.88%-7.38M | 67.86%-800K | 34.40%-1.66M | 25.42%-1.47M | -304.45%-3.45M | -309.62%-7.84M | -227.07%-2.49M | -173.05%-2.52M |
Net business purchase and sale | --0 | --0 | 66.96%-5M | --0 | --0 | --0 | 67.34%-5M | ---15.13M | --155K | --0 |
Net other investing changes | -52.55%-418K | -186.89%-1.12M | -2.21%-1.16M | -2.66%-347K | 25.51%-146K | 46.48%-274K | -357.65%-389K | 12.60%-1.13M | -7.99%-338K | 23.44%-196K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 25.57%-1.3M | 77.75%-1.97M | 43.86%-13.53M | 57.07%-1.15M | 33.76%-1.8M | 29.22%-1.74M | 45.59%-8.84M | -651.51%-24.1M | -148.79%-2.67M | -130.42%-2.72M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 941.74%2.04M | 336.14%392K | 403.57%3.49M | 654.07%1.36M | 1,077.99%2.53M | 31.64%-242K | 42.76%-166K | -107.14%-1.15M | -402.04%-246K | 76.33%-259K |
Net issuance payments of debt | -25.74%-513K | -34.78%-496K | -41.31%-1.67M | -123.17%-549K | -31.66%-341K | -15.25%-408K | -15.00%-368K | 61.33%-1.18M | -515.00%-246K | 76.41%-259K |
Net common stock issuance | 1,400.60%2.49M | 339.60%888K | ---- | ---- | --2.87M | --166K | 573.33%202K | ---- | ---- | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | 17,080.00%5.15M | ---- | ---- | ---- | ---- | -97.12%30K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 941.74%2.04M | 336.14%392K | 403.57%3.49M | 654.07%1.36M | 1,077.99%2.53M | 31.64%-242K | 42.76%-166K | -107.14%-1.15M | -402.04%-246K | 76.33%-259K |
Net cash flow | ||||||||||
Beginning cash position | 28.81%3.47M | -76.10%2.69M | -54.59%11.25M | -83.00%1.86M | -90.56%1.21M | -76.92%2.7M | -54.59%11.25M | 111.43%24.77M | -51.12%10.92M | -52.30%12.79M |
Current changes in cash | 222.44%1.82M | 109.02%772K | 36.25%-8.56M | 108.73%837K | 140.26%649K | -269.02%-1.48M | 34.61%-8.56M | -203.27%-13.42M | -83.26%401K | 64.34%-1.61M |
Effect of exchange rate changes | 433.33%20K | 55.56%14K | 98.02%-2K | 93.42%-5K | --0 | -102.64%-6K | 28.57%9K | -274.14%-101K | -362.07%-76K | -639.58%-259K |
End cash Position | 340.02%5.31M | 28.81%3.47M | -76.10%2.69M | -76.10%2.69M | -83.00%1.86M | -90.56%1.21M | -76.92%2.7M | -54.59%11.25M | -54.59%11.25M | -51.12%10.92M |
Free cash from | 120.45%198K | 149.83%1.5M | -247.36%-5.89M | -121.57%-179K | -50.22%-1.74M | -156.12%-968K | -215.59%-3M | 321.45%4M | -69.89%830K | 63.51%-1.16M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.